CJC-1295 + Ipamorelin Cost: Why the Cheap Vial Rarely Stays Cheap

When you're pricing CJC-1295 plus ipamorelin, the medication cost is straightforward. The real expense lives in the details. Current 2026 comparisons show about $150–$300 from compounding pharmacies or roughly $200–$400 per month through clinic programs —but that's before consults, baseline labs, supplies, and the question of whether this compounded access path still makes sense for your goals.

The medication cost, before everything else gets added

CJC-1295 plus ipamorelin sits in the mid-range of peptide stacks—not a bargain, but not premium-tier either. One 2026 market survey places it at about $150–$300 a month, while a clinic-focused comparison resource lists about $200–$400 monthly. The spread is wide enough to matter, but narrow enough to show the pattern: once you move through a clinic system, you're almost always paying more than the vial itself suggests.

• Medication cost for the peptide blend or separate vials.
• Initial consult fee, which many programs bill separately.
• Baseline and follow-up labs if the clinic monitors IGF-1 or other markers.
• Supplies such as syringes, alcohol swabs, and bacteriostatic water when they are not bundled.
• Shipping, refill cadence, and membership-style follow-up charges.

Why clinic quotes can vary so dramatically

Three drivers move the number. First, some clinics bundle everything; others nickel-and-dime. Second, your protocol is individualized, so frequency, vial form, and refill size change your actual spend. Third, this stack gets marketed as a step up from sermorelin, which is why it typically costs more than the all-in pricing in The Sermorelin Cost Trap and sits closer to the premium setup described in The CJC-1295 + Ipamorelin Stack, Explained for Training Focus.

The higher price tag has reasoning behind it. Human data on CJC-1295 in healthy adults and ipamorelin pharmacodynamics in volunteers supports the clinical pitch: longer GH stimulation paired with a separate ghrelin signal. It explains the sales narrative. It doesn't make the stack FDA-approved or easy to comparison-shop, but it does explain why clinics price it where they do.

The compounding-access question that changes costs

Here's what most pricing pages skip: FDA's current CJC-1295 compounding review reveals a complex picture. The briefing notes that several websites recommend this stack, yet also states that FDA couldn't identify any pharmacies actually compounding CJC-1295 during its search—and the agency is proposing to exclude CJC-1295-related substances from the 503A bulk list. On ipamorelin, FDA separately flags that compounded ipamorelin acetate carries immunogenicity and impurity risks.

FDA is proposing that CJC-1295 DAC acetate NOT be included on the 503A Bulks List.

In practice, this means your monthly cost depends on a less stable supply path than many you realize. You're not just buying peptides. You're paying for a clinic or pharmacy relationship in a category that exists outside FDA approval—which is why quotes can feel solid one month and uncertain the next.

The questions that actually matter

• Is the monthly number medication only, or does it include consults, labs, shipping, and supplies?
• Are you being quoted a combined vial, separate vials, or a program where dose adjustments change price later?
• How often are follow-up visits required, and are they billed separately?
• Which pharmacy is filling the prescription, and is the clinic clear about whether access depends on compounded supply?
• If side effects show up, does the program include support, or does every adjustment trigger another fee?

When this stack makes financial sense

This stack makes sense when you already know you want an injectable growth-hormone routine and you're ready to pay for professional management. If you're still deciding whether you like the category, or haven't yet worked through the practical tradeoffs covered in Ipamorelin Side Effects That Show Up in Your Training Week, the monthly cost can outweigh the upside fast.

What to expect

Expect CJC-1295 plus ipamorelin to run a few hundred dollars a month through a clinic setup—often more once labs and monitoring land on the bill. The smart move isn't chasing the lowest quote. It's clarifying what's included, assessing access stability, and deciding whether an unapproved compounded stack still makes sense after you factor in the full routine, not just the vial.